You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 100 No. 3, September 1960 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Prevention of Type Specific Immunity to Streptococcal Infections Due to the Therapeutic Use of Penicillin

Occurrence of Second Attacks Due to the Same Type of Group A Hemolytic Streptococci

B. B. BREESE, M.D.; FRANK A. DISNEY, M.D.; W. B. TALPEY, M.D.

Am J Dis Child. 1960;100(3):353-359.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In 1954, less than 10 years after penicillin came into general use and had been shown to be an exceedingly effective drug against streptococcal infection in children, Maclyn McCarty1 voiced the following warning: "The extensive use of penicillin throughout childhood may ultimately result in an adult population with a susceptibility to streptococcal disease comparable to that kind we find in school children." This warning was based on the observation that treatment with penicillin interfered with the development of type-specific immunity, which is considered to be the foundation of adult immunity to streptococcal infection. Since the basic studies of Denny, Wannamaker, Brink, Rammelkamp, and Custer2 indicate that prevention of rheumatic fever can be attained by adequate therapy of the initial streptococcal infection with penicillin, this leaves the physician between the horns of a dilemma. If he treats streptococcal infections adequately he interferes with the development of type-specific immunity. If . . . [Full Text PDF of this Article]


Author Affiliations

Rochester, N.Y.

Department of Pediatrics, University of Rochester School of Medicine and Dentistry.


Footnotes

Submitted for publication April 9, 1960.

2333 Elmwood Ave. (18).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1960 American Medical Association. All Rights Reserved.